This paper is only available as a PDF. To read, Please Download here.
Abstract
Background
Cost-effectiveness analysis often requires information on the effectiveness of interventions on multiple outcomes, and commonly these take the form of competing risks. Nevertheless, methods for synthesis of randomized controlled trials with competing risk outcomes are limited.
Objective
The aim of this study was to develop and illustrate flexible evidence synthesis methods for trials reporting competing risk results, which allow for studies with different follow-up times, and that take account of the statistical dependencies between outcomes, regardless of the number of outcomes and treatments.
Methods
We propose a competing risk meta-analysis based on hazards, rather than probabilities, estimated in a Bayesian Markov chain Monte Carlo (MCMC) framework using WinBUGS software. Our approach builds on existing work on mixed treatment comparison (network) meta-analysis, which can be applied to any number of treatments, and any number of competing outcomes, and to data sets with varying follow-up times. We show how a fixed effect model can be estimated, and two random treatment effect models with alternative structures for between-trial variation. We suggest methods for choosing between these alternative models.
Results
We illustrate the methods by applying them to a data set involving 17 trials comparing nine antipsychotic treatments for schizophrenia including placebo, on three competing outcomes: relapse, discontinuation because of intolerable side effects, and discontinuation for other reasons.
Conclusions
Bayesian MCMC provides a flexible framework for synthesis of competing risk outcomes with multiple treatments, particularly suitable for embedding within probabilistic cost-effectiveness analysis.
Keywords
References
- Multivariate meta-analysis.Stat Med. 2003; 22: 2309-2333
- An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes.Stat Med. 2007; 26: 78-97
- Multiple-outcome meta-analysis of clinical trials.Stat Med. 1996; 15: 537-557
- Meta-analysis of multiple outcomes by regression with random effects.Stat Med. 1998; 17: 2537-2550
- A method for the meta-analysis of mutually exclusive binary outcomes.Stat Med. 2008; 27: 4279-4300
- Markov Chain Monte Carlo in Practice. Chapman & Hall/CRC, London1996
- Schizophrenia: The NICE Guidelines on Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Updated edition. British Psychological Society and Royal College of Psychiatrists, Leicester & London2010
- Analysis of Survival Data. Chapman & Hall Ltd, London1984
- Assessing evidence consistency in mixed treatment comparisons.J Am Stat Assoc. 2006; 101: 447-459
- Network meta-analysis for indirect treatment comparisons.Stat Med. 2002; 21: 2313-2324
- Borrowing strength from external trials in a meta-analysis.Stat Med. 1996; 15: 2733-2749
- Simultaneous comparison of multiple treatments: combining direct and indirect evidence.BMJ. 2005; 331: 897-900
Spiegelhalter DJ, Best N, Carlin BP. Bayesian deviance: the effective number of parameters, and the comparison of arbitrarily complex models. Division of Biostatistics: University of Minnesota, 1998.
- Bayesian measures of model complexity and fit.J R Stat Soc Series B Stat Methodol. 2002; 64: 583-616
- A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence.Appl Stat. 2005; 54: 385-404
- WinBUGS user manual version 1.4 January 2003. Upgraded to Version 1.4.3.([Accessed July 20, 2010].)
- Alternative methods for monitoring convergence of iterative simulations.J Comput Graph Stat. 1998; 7: 434-455
- Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple-treatments meta-analysis.Lancet. 2009; 373: 746-758
- What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.Stat Med. 2004; 23: 1351-1375
- Much ado about nothing: a comparison of the performance of meta-analysis methods with rare events.Stat Med. 2006; 26: 53-77
- Modelling between-trial variance structure in mixed treatment comparisons.Biostatistics. 2009; 10: 792-805
- Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis and model calibration.Med Decis Making. 2005; 25: 633-645
- Meta-analysis of mixed treatment comparisons at multiple follow-up times.Stat Med. 2007; 26: 3681-3699
- Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B.Stat Med. 2008; 27: 5620-5639
Article info
Identification
Copyright
© 2010 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
User license
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
